Donate

When you buy an overpriced medicine at the pharmacy, a complex network of players has taken a quiet cut. They aim to keep it that way.
A retired Tennessee physician and professor watches his state shred the medical safety net of his state. Just when I thought things couldn’t get much worse for the TennCare program, they did. (TennCare is Tennessee’s Medicaid managed care program.) First, Medicaid has not been expanded under the Affordable Care Act in...
Were it not for the business practices of some of the biggest corporations in America that profit from the manufacture and distribution of massive quantities of opioids, many of those we have lost likely would still be with us. How are those big corporations responding? In one notable case...
An Appalachian physician explains how health care system mergers result in staff layoffs and have negative effects on his community’s economy.
The coveted treat was quietly delivered by lawmakers who had long sought oil extraction in wildlife refuge.
You would think that making the prices charged by hospitals and doctors available to their patients would be a no-brainer.  After all, we’ve become accustomed to knowing the price we pay for cars, carrots, comic books, and almost everything else we buy. Why not knee surgery or appendectomies? The medical...
This story was written for Tarbell.org. It was co-published with the Hancock Herald in Hancock, N.Y., and 100 Days in Appalachia. Most of Betty Rosengrant’s extended family needs Medicaid. They’re also mostly Republicans. Rosengrant says she knows Republicans have proposed cuts to the federal/state health care system, but that “people...
I’ve been thinking a lot about health-care mergers and acquisitions lately, and I must confess, it’s making me dizzy. All of this head-spinning thought was prompted primarily by the creation of Ballad Health Care, now the sole hospital system for my entire region of the country. Ballad was established about...
Insurance company CEOs and their shareholders, that’s who.
Last month, the New York Times ran a cautionary tale about the heart surgery and care astronaut Neil Armstrong received and his death two weeks later at a community hospital in a Cincinnati suburb in 2012. The Times had received documents from an anonymous tipster who said he/she was “compelled...
Health care industry propagandists proceed cautiously at first-ever hearing on Medicare For All bill.
This New York City subway ad recently caught my attention: “When researching hospitals, consider how much research they do.” The ad for Mt. Sinai Health System advised riders that the research “we do today drives medicine we will do tomorrow,” and the hospital system was proud that it ranked...
Tarbell is highlighting the government fines and penalties businesses pay when they engage in fraudulent or criminal behavior. Often, these fines are just a small part of the firms’ annual revenue and don’t actually serve as a deterrent. To these companies, it’s just the cost of doing business. Some pharmaceutical...
The Senate Special Committee on Aging has just released one of the most damning reports on the nation’s nursing homes that I’ve seen in a long time. The short document should be required reading for any family thinking of moving a relative to a nursing facility. Pennsylvania Senator Robert Casey,...
Many Medicare Advantage plans have small networks and high deductibles. If you go out of network, even unknowingly, you will be on the hook for a lot of money out of your own pocket.
Addressing the problem will require private and public sector to agree on causes and solutions.
When affording health care is already a burden for Americans in rural and underserved regions, making patients spend additional hours and gas money for basic and emergency health needs adds insult to injury. Yet this is exactly what Tennessee and Virginia lawmakers allowed to happen.  In 2018, two rival health...
The new Martin Shkreli is Nostrum Laboratories’ Nirmal Mulye – who raised the price of a bladder infection antibiotic from $475 a bottle to nearly $2,400 a bottle.
If prescription drugs are cheaper in other countries, why not allow Americans to import them? In many cases we’re talking about bringing back drugs that U.S. companies made in the first place. To be sure, re-importation has long been a popular idea with individuals and some policy makers. But no...
Is the beloved program on its last legs?